Abstract
A 50-year-old man with adult respiratory distress syndrome (ARDS) was successfully treated with synthetic surfactant. The therapy rapidly improved the respiratory function; it also increased the release of endogenous surfactant. Synthetic surfactant may thus be of value in the treatment of ARDS.
MeSH terms
-
Drug Combinations
-
Fatty Alcohols / therapeutic use*
-
Humans
-
Male
-
Middle Aged
-
Phosphorylcholine*
-
Polyethylene Glycols / therapeutic use*
-
Pulmonary Surfactants / therapeutic use*
-
Respiratory Distress Syndrome / drug therapy*
Substances
-
Drug Combinations
-
Fatty Alcohols
-
Pulmonary Surfactants
-
Phosphorylcholine
-
Polyethylene Glycols
-
dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination